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Background: Neonatal convulsions are clinical manifestations in a heterogeneous group
of disorders with different etiology and outcome. They are attributed to several genetic
causes.
Methods: We describe a patient with intractable neonatal seizures who died from
respiratory compromise during a status epilepticus.
Results:This case report provides electroencephalogram (EEG), MRI, genetic analysis, and
neuropathological data. Genetic analysis revealed a de novo heterozygous missense muta-
tion in the KCNQ2 gene, which encodes a subunit of a voltage-gated potassium channel.
KCNQ2 gene mutation is associated with intractable neonatal seizures. EEG, MRI, data
as well as mutation analysis have been described in other KCNQ2 cases. Post-mortem
neuropathological investigation revealed mild malformation of cortical development with
increased heterotopic neurons in the deep white matter compared to an age-matched con-
trol subject.The new finding of this study is the combination of a KCNQ2 mutation and the
cortical abnormalities.
Conclusion: KCNQ2 mutations should be considered in neonates with refractory epilepsy
of unknown cause. The mild cortical malformation is an important new finding, though it
remains unknown whether these cortical abnormalities are due to the KCNQ2 mutation or
are secondary to the refractory seizures.
Keywords: neonatal, neonatal seizures, KCNQ2 mutation, ion channel gene defect, cortical dysplasia, MRI
CASE DESCRIPTION
The patient was a pre-term born male [36 6/7 weeks, birth weight
3.4 kg (−1 SD)], head circumference 34 cm (−1.5 SD), and the
second child of non-consanguineous parents. The pregnancy was
uneventful, but the mother reported the occurrence of jittery fetal
movements during the last trimester. At postnatal day 1, the child
developed generalized and multifocal tonic seizures preceded by
a high piercing cry and accompanied by desaturation and brady-
cardia. He subsequently developed left-sided limb and facial jerks
accompanied again by desaturations. He showed mild dysmorphic
features, retrognathia, and small hollow eyes. Neurological exami-
nation showed hypotonia, jitteriness, and absence of blinking and
sucking reflex. At day 24, seizure frequency increased and non-
invasive breathing support became necessary because of decreased
spontaneous breathing. Physical examination showed persistent
hypotonia and jitteriness, intermittent biking movements, absent
sucking and search reflexes, and adducted thumbs.
Biochemical screening (serum electrolytes, glucose level,
ammonia, and routine urine examination) was unremarkable.
Metabolic investigation showed no abnormalities (including
analysis for tyrosinemia, urea cycle defect and creatine syn-
thesis defect, disturbances in purine, pyrimidine, and carbohy-
drate metabolism, and CSF lactate). Subsequent treatment with
midazolam, folic acid, pyridoxal phosphate, levetiracetam, and
phenobarbital was not successful.
The child died on day 25 due to respiratory insufficiency during
a status epilepticus. Electroencephalogram (EEG) at day 5 showed
a non-synchronized immature background pattern with multiple
focal sharp waves predominant over the right hemisphere and sub-
clinical seizures lasting up to 40 s. At day 25, the EEG pattern was
characterized by sharp waves and focal seizures isolated on the left
hemisphere (Figure 1).
Magnetic resonance imaging (MRI; Siemens Sonata 1.5 T,
Erlangen, Germany) at day 7 showed discrete swelling and hyper-
intensity of the basal nuclei (T1-weighted imaging; Figure 2).
Diffusion-weighted images were normal (data not shown). MR
proton spectroscopy showed normal concentrations of creatine,
choline, and N -acetylaspartate and low lactate (data not shown).
Post-mortem MRI examination showed no abnormalities (data
not shown).
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FIGURE 1 | Electroencephalogram recording on day 25. The EEG shows a non-synchronized pattern with suppressions, multifocal sharp waves, and a focal
epileptic seizure in the left hemisphere.
FIGURE 2 | MRI findings on day 7. (A) T1-weighted MRI (inversion
recovery) shows discrete swelling of the basal nuclei and thalamus.
(B) T2-weighted MRI shows a decreased signal in basal nuclei and
thalamus.
NEUROPATHOLOGICAL METHODS
Autopsy was performed at the VU University medical center 12 h
post-mortem. The results were compared with an age-matched
control subject without significant confounding neuropatholog-
ical findings. With the parents’ informed consent, the tissue was
obtained and used in a manner in accordance with the Declaration
of Helsinki.
The brain was fixed in buffered 4% formalin. After fixation,
the cerebral hemispheres were cut in 10 coronal slices and the
brainstem and cerebellum in 7 axial slices. Tissue samples were
taken bilaterally from all cerebral lobes, the nucleus accumbens,
lentiform nucleus, thalamus and subthalamus, hippocampus and
cerebellar white matter with the nucleus dentatus, and cortex of the
inferior semilunar lobe. The brainstem was sampled at the level of
the midbrain, mid-pons and medulla oblongata. After embedding
in paraffin, the tissue was sectioned at 6µm and stained for Hema-
toxylin and Eosin (H&E), Nissl and Luxol fast blue-periodic acid
Schiff according to standard methods. Additionally, tissue sections
were incubated with antibodies against the following epitopes:
glial fibrillary acidic protein (GFAP; Millipore, 1:1000), vimentin
(DAKO, 1:1000); proteolipid protein (PLP; AbDSerotec, 1:3000),
neuronal nuclear antigen (NeuN; Sigma, 1:500), microtubule-
associated protein 2 (MAP2; Chemicon, 1:500), phosphorylated
and non-phosphorylated neurofilament (SMI31 and SMI311,
respectively; Covance, 1:1000), and human leukocyte antigen
(HLA)-DP, -DQ, -DR (CR3/43; DAKO; 1:400). Briefly, sections
were deparaffinized and rehydrated. Endogenous peroxidase activ-
ity was quenched by incubating the slides in 0.3% hydrogen
peroxide in methanol. Heat-induced antigen retrieval was per-
formed in citric acid (0.01 M, pH6) using microwave irradiation
for 15 min on low setting. Tissue sections were incubated overnight
with primary antibodies, and the staining was developed with
diaminobenzidine tetrachloride. Sections were counterstained
with hematoxylin, dehydrated, and mounted with polyvinyl alco-
hol medium with DABCO (Sigma). Negative controls by omitting
the primary antibody were included in each experiment and were
essentially blank. Tissue sections including the cortex and under-
lying white matter extending to the ventricles were obtained from
both frontal lobes just ventral to the nucleus accumbens and
stained with the neuronal-specific markers MAP2 and NeuN. Indi-
vidual MAP2- and NeuN-immunoreactive neurons were counted
Frontiers in Pediatrics | Neonatology December 2014 | Volume 2 | Article 136 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dalen Meurs-van der Schoor et al. Severe neonatal KCNQ2 associated encephalopthy
manually on 10 images taken at 100× magnification of the deep
white matter (>500µm below the cortical boundary) and the den-
sity of ectopic neurons was expressed as number of immunoreac-
tive cells per square millimeter. MAP2 and NeuN stained sections
gave similar results.
At gross examination, the brain had a normal structure with
preservation of the neocortical gyral pattern. Microscopic exam-
ination of the cerebral cortex showed a six-layered architec-
ture without obvious dyslamination or columnar disorganization
(Figure 3A) (see additional materials for details). Occasional
neuronal clustering in cortical layers V and VI was observed in
the frontal lobes (Figure 3D). The interface between cortex and
underlying white matter was diffusely blurred by the presence
of heterotopic neurons displaced to the white matter, as com-
pared to normal (Figures 3B,C). Numerous individual neurons
were also found in deep white matter locations (mean 47 MAP2+
neurons/mm2; mean 6 MAP+ neurons/mm2 in the age-matched
control) (Figures 3E,F). These heterotopic neurons had normal
morphology and immunophenotypic profile (Figure 3G). No dys-
morphic neurons or balloon cells were seen. The cortex and under-
lying white matter displayed intense reactive gliosis (Figure 3H).
The white matter contained virtually no mature myelin, as
expected for the age. No hippocampal sclerosis or other lesions
were found. No abnormalities were found in the cerebellum,
including cortex and dentate nucleus. These features are consistent
with malformation of cortical development (mMCD) (1–3).
Genetic analysis disclosed a de novo heterozygous missense
mutation (c.643G<A; p.Gly215Arg) in the KCNQ2 gene (refer-
ence sequence NM_172107.2).
BACKGROUND
Neonatal convulsions are clinical manifestations in a heteroge-
neous group of disorders with different etiology and outcome.
Benign familial neonatal convulsion (BFNC) is characterized
by a benign course with spontaneous remission and a moderate
risk for development of epilepsy later in life (4).
Benign familial neonatal convulsion is defined by the follow-
ing criteria: occurrence of frequent brief seizures on or after the
second day of life, which disappear spontaneously within a few
weeks; positive family history with an autosomal dominant inher-
itance pattern; exclusion of other causes of neonatal seizures; and
normal physical examination and subsequent neurodevelopment
(4, 5). BFNC is caused by mutations in two genes, KCNQ2 and
KCNQ3 (6, 7). In addition, KCNQ2 mutations have been found
in a few patients with refractory neonatal seizures similar to the
Ohtahara syndrome (4). In our patient, genetic analysis revealed
a de novo heterozygous missense mutation in the KCNQ2 gene,
which encodes a subunit of a voltage-gated potassium channel.
In affected families with BFNC, the individuals who later pre-
sented with delayed psychomotor development or mental retarda-
tion showed mutations located on the KCNQ2 gene (1) suggesting
an association between KCNQ2 mutations and encephalopathy.
EEG, MRI data, as well as mutation analysis have been described
in other KCNQ2 cases (8). This case report provides EEG, MRI,
genetic analysis, and neuropathological data. Neuropathological
investigation revealed a mild mMCD (1–3). The new finding of
this study is the combination of a KCNQ2 mutation and mMCD.
DISCUSSION
There is significant literature on potassium-channel gene muta-
tions in the brain and various types of epilepsy (9–11). There are
many animal models to study potassium channels and mecha-
nism for hyperexcitability and correlates of genetic mutations in
the KCNQ2 gene (4, 12, 13). Literature shows increased seizure
susceptibility in rats with induced nodular heterotopia. These het-
erotopic neurons showed inactivated expression of Kv4.2 subunits
in cultured cells (13). Potassium channels play critical roles in
modulating neuronal excitability and mutations in these channels
can result in severe epileptic phenotypes, as we describe in our
study.
KCNQ2 encodes a subunit of a voltage-gated potassium chan-
nel. It is expressed in the central nervous system from 22 weeks
gestational age onward, where it inhibits neuronal excitability (14).
KCNQ2 mutations are associated with different clinical pheno-
types, including typical BFNC (5, 9) and neonatal or early infantile
epilepsy (BFNIS) (7). Changes in the KCNQ2 gene have been
identified in 60–70% of families with BFNC (7).
Benign familial neonatal convulsion seizures are characterized
by a tonic component followed by a range of motor phenom-
ena associated with ocular symptoms, dyspnea, and autonomic
signs. Seizures are usually brief but can evolve into status epilep-
ticus. Typically, BFNC has a good outcome with most patients
being seizure-free after 6 months. However, several patients with
a severe encephalopathy phenotype of KCNQ2-related neonatal
seizures have also been reported (14, 15).
Most of the reported KCNQ2 encephalopathies were diag-
nosed as Ohtahara syndrome showed a burst suppression EEG
pattern and infrequently involuted to West syndrome with poor
developmental outcome (8).
KCNQ2 encephalopathy is characterized by onset of intractable
seizures in the first week of life with a prominent tonic compo-
nent in the first week of life. In line with a previous study (14), the
mother of our patient reported jittery fetal movements in the last
trimester of pregnancy, suggesting that seizures onset may be pre-
natal. MRI findings include discrete signal hyperintensity of the
basal nuclei and thalamus, which are different from those typically
observed in patients with hypoxic–ischemic encephalopathy (7).
Although seizures resolved before 3 years of age, surviving patients
were left with intellectual disability and motor impairment (14).
Our patient carried a de novo mutation in the KCNQ2 gene.
The resulting p.Gly215Arg amino-acid change is located in the
S4 transmembrane domain, which acts as the voltage-sensor of
the potassium-channel subunit Kv7.2. Mutation in this domain
was also found in two patients in the series of Weckhysen et al.
(14). It is hypothesized that mutations in this area are associated
with the more severe phenotype of encephalopathy (14). Whether
KCNQ2 encephalopathy patients may benefit from potassium-
channel openers remains to be established (4). They could benefit
from carbamazepine, stabilizing the inactive state of voltage-
gated sodium channels, followed by retigabine, which increases
the potassium current through KCNQ2 channels (16). The elec-
troclinical and early radiological features of our patient were
consistent with a KCNQ2 encephalopathy. However, the seizure
frequency progressively increased despite a broad anti-epileptic
regimen and the child died during a status epilepticus. As already
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FIGURE 3 | Histopathology of the frontal cortex shows mild malformation of cortical development.
(Continued)
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FIGURE 3 | Continued
(A) H&E staining at low magnification shows a normal six-layered
architecture of the cortex. (B) At high magnification of the cortex and
cortical boundary, heterotopic neurons displaced to the white matter make
it difficult to distinguish between the gray and white matter border (H&E).
(C) In the frontal cortex of a control subject, the gray–white matter
junction appears sharply demarcated (H&E). (D) Abnormal clusters of
SMI31-immunoreactive neurons (arrow) are visible in the deep cortical
layers. (E,F) The deep white matter (>500 mm from the cortical border)
shows increased cellularity by heterotopic neurons [(E), stain against the
microtubule associated protein 2 (MAP2); (F) stain against extranuclear
RNA identifying neurons]. (G) The heterotopic neurons in the deep white
matter, identified by their MAP2-immunoreactivity, have normal
morphology and immunophenotype. (H) The deep white matter harboring
the heterotopic neurons is gliotic with numerous vimentin-positive
reactive astrocytes. (A) 25×; (B,C,E,F) 100×; (D,G,H) 200×.
reported, the EEG showed a non-synchronized pattern with mul-
tifocal sharp waves and multifocal neonatal seizures. The elec-
troclinical features closely resembled the Ohtahara syndrome, in
line with the severity of the epileptic encephalopathy. These burst
suppression patterns with associated interictal multifocal spikes
and polyspikes in association with the specific neonatal clinical
epileptiform activity must be taken into account in the diagnos-
tic work-up of neonatal encephalopathies, which also includes
KCNQ2 testing (16, 17).
The association of KCNQ2 mutations and refractory epilep-
sia with neuropathological abnormalities has not been described.
Studies confirm an association between KCNQ2 mutation and
neonatal onset epileptic encephalopathy (18). The new find-
ing of this study is the combination of a KCNQ2 mutation
and mMCD.
The neuropathological findings were consistent with mMCD.
mMCD is characterized by neuronal clusters or an excess of sin-
gle neurons with normal morphology in the deep white matter
in the absence of other lesions (1, 2, 19). White matter neurons
are a normal finding in the mature brain (2). A proportion of
these cells are likely to be remnants of subplate cells, impor-
tant for the establishment of thalamo-cortical pathways during
development. In the mature brain, white matter neurons include
excitatory as well as inhibitory interneurons possibly function-
ally integrated into cortical circuits (20). However, numerous
studies confirm excessive numbers of white matter neurons in
epilepsy patients (21). The finding of heterotopic neurons in our
patient might explain the persistence of intractable seizures with
the fatal course. Possible explanations for a microscopic neuronal
heterotopia are either developmental abnormality (i.e., hetero-
topic neurons following failure of normal migration), a matu-
rational abnormality (abnormal persistence of subplate neurons
following corticogenesis) or neurogenesis, possibly influenced by
seizures.
In conclusion, KCNQ2 mutations should be considered in
neonates with refractory epilepsy of unknown cause. The mild cor-
tical malformation is an important new finding, though it remains
unknown whether the observed cortical abnormalities are causally
related to the KCNQ2 mutation or are secondary to the refractory
seizures.
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